The FDA has approved a generic version of lenalidomide, a drug used to treat multiple myeloma and myelodysplastic syndromes, with availability set for Jan. 31, 2026.

Scientists believe we start to see signs of hair-thinning from the age of 40, with around 6.5 million men in the United ...

Are you facing hair thinning and want to restore your luscious locks? Don't fret. We talked to dermatologists to understand ...

MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...